Intra-Cellular Therapies Inc. buy Piper Sandler
Start price
06.09.24
/
50%
€67.00
Target price
06.09.25
€82.70
Performance (%)
83.58%
End price
07.09.25
-
Summary
This prediction is currently being closed. With a performance of 83.58% the BUY prediction by Piper_Sandler is a big success. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intra-Cellular Therapies Inc. | - | - | - |
| iShares Core DAX® | 0.437% | 5.897% | 8.047% |
| iShares Nasdaq 100 | 1.057% | 0.920% | 28.466% |
| iShares Nikkei 225® | 1.769% | 1.228% | 47.574% |
| iShares S&P 500 | 0.368% | 1.920% | 23.200% |
Comments by Piper_Sandler for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $92.00 price target on the stock, up previously from $68.00.
Ratings data for ITCI provided by MarketBeat
In the thread Trading Intra-Cellular Therapies Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten